A detailed history of American Trust Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, American Trust Investment Advisors, LLC holds 2,422 shares of AMGN stock, worth $713,351. This represents 0.34% of its overall portfolio holdings.

Number of Shares
2,422
Previous 2,496 2.96%
Holding current value
$713,351
Previous $779,000 0.13%
% of portfolio
0.34%
Previous 0.41%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $22,894 - $24,966
-74 Reduced 2.96%
2,422 $780,000
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $39,412 - $47,896
-150 Reduced 5.67%
2,496 $779,000
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $36,566 - $44,140
-136 Reduced 4.89%
2,646 $752,000
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $83,102 - $93,749
-325 Reduced 10.46%
2,782 $801,000
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $24,051 - $29,860
-110 Reduced 3.42%
3,107 $835,000
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $22,926 - $27,110
107 Added 3.44%
3,217 $714,000
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $7,902 - $9,632
-35 Reduced 1.11%
3,110 $751,000
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $8,016 - $10,185
-35 Reduced 1.1%
3,145 $826,000
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $21,099 - $23,796
-94 Reduced 2.87%
3,180 $717,000
Q2 2022

Jul 14, 2022

BUY
$230.71 - $256.74 $1,153 - $1,283
5 Added 0.15%
3,274 $797,000
Q1 2022

Apr 19, 2022

BUY
$219.27 - $242.57 $12,059 - $13,341
55 Added 1.71%
3,269 $791,000
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $46,736 - $53,486
235 Added 7.89%
3,214 $723,000
Q3 2021

Nov 10, 2021

BUY
$212.27 - $248.7 $6,368 - $7,461
30 Added 1.02%
2,979 $633,000
Q2 2021

Aug 10, 2021

BUY
$233.58 - $259.14 $33,869 - $37,575
145 Added 5.17%
2,949 $719,000
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $37,058 - $43,186
-167 Reduced 5.62%
2,804 $698,000
Q4 2020

Jan 29, 2021

BUY
$216.38 - $257.67 $30,725 - $36,589
142 Added 5.02%
2,971 $683,000
Q3 2020

Oct 23, 2020

SELL
$234.65 - $260.95 $55,142 - $61,323
-235 Reduced 7.67%
2,829 $719,000
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $2,967 - $3,641
15 Added 0.49%
3,064 $723,000
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $19,681 - $26,103
108 Added 3.67%
3,049 $618,000
Q4 2019

Feb 11, 2020

BUY
$189.21 - $243.2 $17,596 - $22,617
93 Added 3.27%
2,941 $709,000
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $11,317 - $13,560
-65 Reduced 2.23%
2,848 $551,000
Q2 2019

Aug 12, 2019

SELL
$166.7 - $195.41 $166 - $195
-1 Reduced 0.03%
2,913 $537,000
Q1 2019

May 07, 2019

SELL
$180.87 - $203.88 $26,407 - $29,766
-146 Reduced 4.77%
2,914 $554,000
Q4 2018

Jan 16, 2019

SELL
$178.4 - $208.25 $3,568 - $4,165
-20 Reduced 0.65%
3,060 $596,000
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $12,970 - $14,622
-70 Reduced 2.22%
3,080 $638,000
Q2 2018

Aug 07, 2018

BUY
$166.05 - $186.51 $3,819 - $4,289
23 Added 0.74%
3,150 $581,000
Q1 2018

May 14, 2018

BUY
$169.43 - $198.0 $24,906 - $29,106
147 Added 4.93%
3,127 $533,000
Q4 2017

Feb 05, 2018

BUY
$168.79 - $188.59 $6,751 - $7,543
40 Added 1.36%
2,980 $518,000
Q3 2017

Nov 09, 2017

BUY
$167.29 - $191.0 $491,832 - $561,540
2,940
2,940 $548,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track American Trust Investment Advisors, LLC Portfolio

Follow American Trust Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Trust Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on American Trust Investment Advisors, LLC with notifications on news.